Massimiliano Cazzaniga - Search Results

Year	Number of Results
2000	1
2002	2
2003	3
2004	1
2006	4
2007	1
2008	2
2009	6
2010	1
2011	1
2012	6
2013	3
2014	1
2015	5
2016	3
2017	1
2018	1
2020	1
2022	2
2023	7
2024	5

1

Influence of the microbiota on the effectiveness and toxicity of oncological therapies, with a focus on chemotherapy.

Cazzaniga M, Zonzini GB, Di Pierro F, Palazzi CM, Cardinali M, Bertuccioli A. Cazzaniga M, et al. Pathol Oncol Res. 2023 Aug 2;29:1611300. doi: 10.3389/pore.2023.1611300. eCollection 2023. Pathol Oncol Res. 2023. PMID: 37593337 Free PMC article. Review.

2

Metformin: risk-benefit profile with a focus on cancer.

Provinciali N, Lazzeroni M, Cazzaniga M, Gorlero F, Dunn BK, DeCensi A. Provinciali N, et al. Among authors: cazzaniga m. Expert Opin Drug Saf. 2015 Oct;14(10):1573-85. doi: 10.1517/14740338.2015.1084289. Epub 2015 Sep 11. Expert Opin Drug Saf. 2015. PMID: 26359221 Review.

3

Pharmacoprevention for hereditary breast and ovarian cancer.

Cazzaniga M, Bonanni B. Cazzaniga M, et al. Minerva Ginecol. 2016 Oct;68(5):517-35. Epub 2016 Feb 29. Minerva Ginecol. 2016. PMID: 26928419 Review.

4

Emerging evidence on the role of breast microbiota on the development of breast cancer in high-risk patients.

Actis S, Cazzaniga M, Bounous VE, D'Alonzo M, Rosso R, Accomasso F, Minella C, Biglia N. Actis S, et al. Among authors: cazzaniga m. Carcinogenesis. 2023 Dec 15;44(10-11):718-725. doi: 10.1093/carcin/bgad071. Carcinogenesis. 2023. PMID: 37793149

5

Breast Cancer Metabolism and Mitochondrial Activity: The Possibility of Chemoprevention with Metformin.

Cazzaniga M, Bonanni B. Cazzaniga M, et al. Biomed Res Int. 2015;2015:972193. doi: 10.1155/2015/972193. Epub 2015 Oct 28. Biomed Res Int. 2015. PMID: 26605341 Free PMC article. Review.

6

Exemestane: one part of the chemopreventive spectrum for ER-positive breast cancer.

Dunn BK, Cazzaniga M, DeCensi A. Dunn BK, et al. Among authors: cazzaniga m. Breast. 2013 Jun;22(3):225-37. doi: 10.1016/j.breast.2013.02.015. Epub 2013 Mar 25. Breast. 2013. PMID: 23535509 Free article. Review.

7

Relationship Between Metabolic Disorders and Breast Cancer Incidence and Outcomes. Is There a Preventive and Therapeutic Role for Berberine?

Cazzaniga M, Bonanni B. Cazzaniga M, et al. Anticancer Res. 2018 Aug;38(8):4393-4402. doi: 10.21873/anticanres.12741. Anticancer Res. 2018. PMID: 30061203 Review.

8

Prevention of ER-negative breast cancer: where do we stand?

Cazzaniga M, Bonanni B. Cazzaniga M, et al. Eur J Cancer Prev. 2012 Mar;21(2):171-81. doi: 10.1097/CEJ.0b013e32834c9c26. Eur J Cancer Prev. 2012. PMID: 21968686 Review.

9

Fenretinide (4-HPR): a preventive chance for women at genetic and familial risk?

Cazzaniga M, Varricchio C, Montefrancesco C, Feroce I, Guerrieri-Gonzaga A. Cazzaniga M, et al. J Biomed Biotechnol. 2012;2012:172897. doi: 10.1155/2012/172897. Epub 2012 Mar 5. J Biomed Biotechnol. 2012. PMID: 22500077 Free PMC article. Review.

10

Breast cancer chemoprevention: old and new approaches.

Cazzaniga M, Bonanni B. Cazzaniga M, et al. J Biomed Biotechnol. 2012;2012:985620. doi: 10.1155/2012/985620. Epub 2012 Jul 17. J Biomed Biotechnol. 2012. PMID: 22851887 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

53 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year